Healthcare

ZJYL.US – JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

2025-01-07T17:23:24+00:00Categories: Medical Instruments & Supplies|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. Address: No. 33 Lingxiang Road, Changzhou, China

ZIVO.US – Zivo Bioscience Inc

2025-01-07T17:23:20+00:00Categories: Biotechnology|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan. Address: 21 East Long Lake Road, Bloomfield Hills, MI, United States, 48304

ZIMV.US – ZimVie Inc

2025-01-07T17:23:09+00:00Categories: Medical Devices|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. It operates through The Dental Segment. The company offers dental implant systems; biomaterials; prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida with additional facilities around the globe. Address: 4555 Riverside Drive, Palm Beach Gardens, FL, United States, 33410

ZCMD.US – Zhongchao Inc

2025-01-07T17:22:19+00:00Categories: Health Information Services|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers patient management services in the tumor and rare diseases field; internet healthcare services, and pharmaceutical services, as well as operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content, as well as sells patent drugs. The company offers its services through its MDMOOC online platform, including MDMOOC mobile App, MOOC Medical WeChat subscription account, and MDMOOC website; and patient management services through IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China. Address: Nanxi Creative Center, Shanghai, China, 200040

ZBIO.US – Zenas BioPharma, Inc. Common Stock

2025-01-07T17:22:08+00:00Categories: Biotechnology|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts. Address: North Building, Waltham, MA, United States, 02451

ZBH.US – Zimmer Biomet Holdings Inc

2025-01-07T17:22:04+00:00Categories: Medical Devices|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Address: 345 East Main Street, Warsaw, IN, United States, 46580

YMAB.US – Y mAbs Therapeutics

2025-01-07T17:20:42+00:00Categories: Biotechnology|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer in the United States and internationally. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow. The company is also developing DANYELZA for the treatment of patients with second-line relapsed osteosarcoma and is in Phase II clinical study; GD2-SADA, which is in Phase I clinical trial for the treatment of GD2 positive solid tumor; and Omburtamab, a murine monoclonal antibody for the treatment of central nervous system/leptomeningeal metastases from neuroblastoma, as well as SADA PRIT technology platform. In addition, it is engages in the developing of CD38-SADA and GD2-GD3 Vaccine. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York. Address: 230 Park Avenue, New York, NY, United States, 10169

YI.US – 111 Inc

2025-01-07T17:20:30+00:00Categories: Medical Distribution|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates in two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China. Address: No.295 ZuChongZhi Road, Shanghai, China, 201203

YCBD.US – cbdMD Inc

2025-01-07T17:19:50+00:00Categories: Drug Manufacturers-Specialty & Generic|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina. Address: 8845 Red Oak Boulevard, Charlotte, NC, United States, 28217

XYLO.US – Xylo Technologies Ltd.

2025-01-07T17:19:42+00:00Categories: Medical Devices|Tags: Healthcare, USA|

Name:
Trailing PE:
Forward PE:
Price Sales TTM:
Price Book MRQ:
Enterprise Value Revenue:
Enterprise Value Ebitda:

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Address: 10 Hanechoshet, Tel Aviv, Israel, 6971072